CD11c expression in B-cell chronic lymphocytic leukemia. A comparison of results obtained with different monoclonal antibodies
S Molica, A Dattilo, A Mannella, D Levato - Haematologica, 1994 - haematologica.org
In order to obtain more information on the pattern of CD11c-positivity in otherwise typical B-
cell chronic lymphocytic leukemia (CLL), we analyzed immunological and clinico …
cell chronic lymphocytic leukemia (CLL), we analyzed immunological and clinico …
[HTML][HTML] CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression
C Rodrigues, P Laranjeira, A Pinho, I Silva… - Frontiers in …, 2024 - frontiersin.org
Introduction In monoclonal B cell lymphocytosis (MBL) and chronic lymphocytic leukemia
(CLL), the expansion of malignant B cells disrupts the normal homeostasis and interactions …
(CLL), the expansion of malignant B cells disrupts the normal homeostasis and interactions …
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia
C Cuesta-Mateos, J Loscertales, A Kreutzman… - Cancer Immunology …, 2015 - Springer
Chronic lymphocytic leukemia (CLL) with deletions of the p 53 locus on chromosome 17
and/or refractory to fludarabine chemoimmunotherapy remains a major clinical problem with …
and/or refractory to fludarabine chemoimmunotherapy remains a major clinical problem with …
Evaluation of CD69 expression as a prognosticator in chronic lymphocytic leukemia
EA Abd El-hadi, YN El-Sakhawy… - The Egyptian Journal of …, 2015 - journals.lww.com
Evaluation of CD69 expression as a prognosticator in chronic... : The Egyptian Journal of
Haematology Evaluation of CD69 expression as a prognosticator in chronic lymphocytic …
Haematology Evaluation of CD69 expression as a prognosticator in chronic lymphocytic …
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
M Hallek, O Al‐Sawaf - American journal of hematology, 2021 - Wiley Online Library
Disease overview Chronic lymphocytic leukemia (CLL) is one of the most frequent types of
leukemia. It typically occurs in elderly patients and has a highly variable clinical course …
leukemia. It typically occurs in elderly patients and has a highly variable clinical course …
CD13 expression in B-cell chronic lymphocytic leukemia is associated with the pattern of bone marrow infiltration
A Pinto, V Zagonel, A Carbone, D Serraino… - Leukemia & …, 1992 - Taylor & Francis
The ectopic expression of the cell surface peptidase CD13 (aminopeptidase N) and of three
other myelomonocytic antigens ie CD33, CD14 and CD15 was analyzed by flow cytometry …
other myelomonocytic antigens ie CD33, CD14 and CD15 was analyzed by flow cytometry …
[PDF][PDF] Utilization of a scoring system for diagnosis of chronic lymphocytic leukemia in Thai patients
CU Auewarakul - J Med Assoc Thai, 2011 - thaiscience.info
Background: Chronic lymphocytic leukemia (CLL) is a rare B-lymphoid malignancy in
Southeast Asia. We evaluated whether a scoring system based on the expression of CD5 …
Southeast Asia. We evaluated whether a scoring system based on the expression of CD5 …
CD 200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry
Introduction Immunophenotyping by flow cytometry is routinely employed in distinguishing
between chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Inclusion of …
between chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Inclusion of …
[PDF][PDF] Prognostic significance of CD38 for chronic lymphocytic leukemia: a meta-analysis
C He, Z Liu, J Ji, H Zhu - International Journal Clinical Experimental …, 2017 - e-century.us
Background and objectives: Numerous studies have focused on the role of CD38 in chronic
lymphocytic leukemia (CLL), but evidence regarding the prognostic value of CD38 with …
lymphocytic leukemia (CLL), but evidence regarding the prognostic value of CD38 with …
[HTML][HTML] CD49d is the strongest flow cytometry–based predictor of overall survival in chronic lymphocytic leukemia
P Bulian, TD Shanafelt, C Fegan… - Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Although CD49d is an unfavorable prognostic marker in chronic lymphocytic
leukemia (CLL), definitive validation evidence is lacking. A worldwide multicenter analysis …
leukemia (CLL), definitive validation evidence is lacking. A worldwide multicenter analysis …